Bocidelpar | m-entrepreneurship.com

Product Name :
Bocidelpar

Search keywords :
Bocidelpar

drugId :
null

Target Vo:
Peroxisome proliferator-activated receptor delta

Target Vo Short Name :
PPARδ

Moa_Name:
Peroxisome proliferator-activated receptor delta modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Astellas Pharma Inc

Active Company_Name :
Astellas Pharma Global Development Inc

Active Indication_Name:
Kidney Diseases

In Active Indication_Name:
Muscular Dystrophy, Duchenne

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HER2 Rabbit mAb Protocol
IRAK-1 Rabbit mAb Description
PDCD4 Antibody: PDCD4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to PDCD4. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts